News
Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...
A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...
Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 new jobs.
GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.
Hundreds of GSK workers have voted to stage a series of walkouts at U.K. manufacturing sites in May over a pay dispute, in what could be a first at the company, Reuters tells us.
GlaxoSmithKline (NYSE: GSK) recently announced this year that it has acquired Okairos AG (Okairos), a specialist developer of vaccine platform technologies for €250 million (approximately £215 ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now.In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results